Strategies and Practices of Clinical Supply Management for Multi-Regional Clinical Trials (IN CHINESE)
Summary:
Biotech studies in China have increasingly become an important part of global drug innovation, and drug developers in China have begun to seek a broader international market for these innovative products. Striving for efficient and flexible implementation of Multi-Regional Clinical Trial (MRCT) operations and supply chain management will be critical for the success of new drugs being developed overseas.
Learn about the MRCT trends in studies from China to overseas, as well as how clinical supply strategy considerations in different clinical phases can help in understanding risk assessment when developing a global supply plan. Additionally, discover how trial complexity factors can influence clinical supply strategy and execution practices as well. This presentation reviews the key points of clinical supply management which can ultimately help lead to the success of global studies, especially for sponsors in China and across the Asia-Pacific region. ***PRESENTATION IS IN CHINESE***